FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320032907> ?p ?o ?g. }

• W4320032907 endingPage "768" @default.
• W4320032907 startingPage "761" @default.
• W4320032907 abstract "Hyperleukocytosis is associated with a significant early mortality rate in patients with acute myeloid leukemia (AML). To date, no controlled trial has ever evaluated a strategy to reduce this risk, and the initial management of these patients remains heterogeneous worldwide. The aim of the present study was to evaluate the influence of a short course of intravenous dexamethasone on the early outcomes of patients with hyperleukocytic AML with white blood cell (WBC) count above 50 × 109/L. Clinical and biological data of all consecutive patients (1997-2017) eligible for intensive chemotherapy from a single center were retrospectively collected. A total of 251 patients with a median age of 51 years and a median WBC count of 120 × 109/L were included, 95 of whom received dexamethasone. Patients treated with dexamethasone had higher WBC count and a more severe disease compared with those who did not, and they presented more often with leukostasis and hypoxemia, resulting in a more frequent need for life-sustaining therapies (p < 0.001). To account for these imbalances, patients were compared after adjusting for a propensity score, which included all variables with a prognostic influence in the overall cohort. In the matched cohort, dexamethasone was associated with lower early death (OR = 0.34, p = 0.0026) and induction failure rate (OR = 0.44, p = 0.02) and better overall survival (HR = 0.60, p = 0.011), with no impact on relapse risk (cHR = 0.73, p = 0.39). The overall survival benefit was confirmed among all tested subgroups. This study suggests that dexamethasone administration is safe and associated with a lower risk of induction mortality in patients with hyperleukocytic AML and deserves prospective evaluation." @default.
• W4320032907 created "2023-02-12" @default.
• W4320032907 creator A5000436961 @default.
• W4320032907 creator A5004876764 @default.
• W4320032907 creator A5007605254 @default.
• W4320032907 creator A5029691900 @default.
• W4320032907 creator A5042494883 @default.
• W4320032907 creator A5048099534 @default.
• W4320032907 creator A5052673276 @default.
• W4320032907 creator A5062366344 @default.
• W4320032907 creator A5064103067 @default.
• W4320032907 creator A5064658190 @default.
• W4320032907 creator A5075335303 @default.
• W4320032907 creator A5076578951 @default.
• W4320032907 creator A5076973611 @default.
• W4320032907 date "2023-02-11" @default.
• W4320032907 modified "2023-10-18" @default.
• W4320032907 title "Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis" @default.
• W4320032907 cites W2007689771 @default.
• W4320032907 cites W2009300493 @default.
• W4320032907 cites W2016908144 @default.
• W4320032907 cites W2042787512 @default.
• W4320032907 cites W2091101255 @default.
• W4320032907 cites W2109573929 @default.
• W4320032907 cites W2116363536 @default.
• W4320032907 cites W2116858301 @default.
• W4320032907 cites W2121108639 @default.
• W4320032907 cites W2124110638 @default.
• W4320032907 cites W2144612883 @default.
• W4320032907 cites W2279689980 @default.
• W4320032907 cites W2559537906 @default.
• W4320032907 cites W2793523845 @default.
• W4320032907 cites W2914048049 @default.
• W4320032907 cites W2918095490 @default.
• W4320032907 cites W2986945259 @default.
• W4320032907 cites W2996044692 @default.
• W4320032907 cites W3004626187 @default.
• W4320032907 cites W3009369530 @default.
• W4320032907 cites W3092971648 @default.
• W4320032907 cites W3129311534 @default.
• W4320032907 cites W4210549391 @default.
• W4320032907 cites W4210642183 @default.
• W4320032907 doi "https://doi.org/10.1007/s00277-023-05119-3" @default.
• W4320032907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36773040" @default.
• W4320032907 hasPublicationYear "2023" @default.
• W4320032907 type Work @default.
• W4320032907 citedByCount "4" @default.
• W4320032907 countsByYear W43200329072023 @default.
• W4320032907 crossrefType "journal-article" @default.
• W4320032907 hasAuthorship W4320032907A5000436961 @default.
• W4320032907 hasAuthorship W4320032907A5004876764 @default.
• W4320032907 hasAuthorship W4320032907A5007605254 @default.
• W4320032907 hasAuthorship W4320032907A5029691900 @default.
• W4320032907 hasAuthorship W4320032907A5042494883 @default.
• W4320032907 hasAuthorship W4320032907A5048099534 @default.
• W4320032907 hasAuthorship W4320032907A5052673276 @default.
• W4320032907 hasAuthorship W4320032907A5062366344 @default.
• W4320032907 hasAuthorship W4320032907A5064103067 @default.
• W4320032907 hasAuthorship W4320032907A5064658190 @default.
• W4320032907 hasAuthorship W4320032907A5075335303 @default.
• W4320032907 hasAuthorship W4320032907A5076578951 @default.
• W4320032907 hasAuthorship W4320032907A5076973611 @default.
• W4320032907 hasBestOaLocation W43200329071 @default.
• W4320032907 hasConcept C126322002 @default.
• W4320032907 hasConcept C141071460 @default.
• W4320032907 hasConcept C17923572 @default.
• W4320032907 hasConcept C194409129 @default.
• W4320032907 hasConcept C2776611710 @default.
• W4320032907 hasConcept C2776694085 @default.
• W4320032907 hasConcept C2777432695 @default.
• W4320032907 hasConcept C2778461978 @default.
• W4320032907 hasConcept C2778488018 @default.
• W4320032907 hasConcept C2778729363 @default.
• W4320032907 hasConcept C2780401358 @default.
• W4320032907 hasConcept C71924100 @default.
• W4320032907 hasConcept C72563966 @default.
• W4320032907 hasConceptScore W4320032907C126322002 @default.
• W4320032907 hasConceptScore W4320032907C141071460 @default.
• W4320032907 hasConceptScore W4320032907C17923572 @default.
• W4320032907 hasConceptScore W4320032907C194409129 @default.
• W4320032907 hasConceptScore W4320032907C2776611710 @default.
• W4320032907 hasConceptScore W4320032907C2776694085 @default.
• W4320032907 hasConceptScore W4320032907C2777432695 @default.
• W4320032907 hasConceptScore W4320032907C2778461978 @default.
• W4320032907 hasConceptScore W4320032907C2778488018 @default.
• W4320032907 hasConceptScore W4320032907C2778729363 @default.
• W4320032907 hasConceptScore W4320032907C2780401358 @default.
• W4320032907 hasConceptScore W4320032907C71924100 @default.
• W4320032907 hasConceptScore W4320032907C72563966 @default.
• W4320032907 hasIssue "4" @default.
• W4320032907 hasLocation W43200329071 @default.
• W4320032907 hasLocation W43200329072 @default.
• W4320032907 hasLocation W43200329073 @default.
• W4320032907 hasOpenAccess W4320032907 @default.
• W4320032907 hasPrimaryLocation W43200329071 @default.
• W4320032907 hasRelatedWork W2050400868 @default.
• W4320032907 hasRelatedWork W2188913058 @default.
• W4320032907 hasRelatedWork W2192167734 @default.

• next